跳至主要内容
临床试验/NCT02035865
NCT02035865已完成不适用

Nevropsykiatri og Hjertetransplantasjon

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
74
试验地点
1
主要终点
Psychiatric morbidity

研究概览

简要总结

The investigators aim at characterizing neuropsychiatric consequences of heart transplantation (HTX) and at assessing the impact of depressive symptoms after HTX on mortality and cardiac allograft vasculopathy (CAV).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Participant in one of two former studies and heart transplanted at the time of inclusion into this former study

排除标准

  • Cognitively not capable to consent to participation and/or
  • Insufficient fluent in the Norwegian language to complete both psychiatric and neuropsychological assessment

结局指标

主要结局

Psychiatric morbidity

时间窗: At time of enrollment

Psychiatric diagnoses by clinician and self-rapport

Cognitive function

时间窗: At time of enrollment

Neuropsychological assessment

次要结局

  • Cardiac allograft vasculopathy(14 and 3 years respectively)
  • All cause mortality(14 and 3 years respectively)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ira Hebold Haraldsen

MD, dr.philos.

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验

Mood and Cognitive Outcome After Heart... | 临床试验